RGEN - Repligen Corporation

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
801,536
801,536
670,534
366,260
270,245
Cost of revenue
345,830
345,830
279,280
156,634
119,099
Gross profit
455,706
455,706
391,254
209,626
151,146
Operating expenses
Research development
43,936
43,936
34,274
20,182
19,450
Selling general and administrative
215,829
215,829
183,866
119,621
95,613
Total operating expenses
259,765
259,765
218,140
139,803
115,063
Operating income or loss
195,941
195,941
173,114
69,823
36,083
Interest expense
1,162
1,162
12,714
12,133
9,292
Total other income/expenses net
26,176
26,176
-6,857
1,527
-640
Income before tax
219,140
219,140
153,543
59,217
26,151
Income tax expense
33,181
33,181
25,252
-709
4,740
Income from continuing operations
185,959
185,959
128,291
59,926
21,411
Net income
185,959
185,959
128,291
59,926
21,411
Net income available to common shareholders
185,959
185,959
128,291
59,926
21,411
Basic EPS
-
3.35
2.33
1.14
0.44
Diluted EPS
-
3.24
2.24
1.11
0.44
Basic average shares
-
55,460
55,015
52,554
48,343
Diluted average shares
-
57,455
57,264
53,892
49,206
EBITDA
-
220,302
166,257
71,350
35,443